Higher Free Triiodothyronine Is Associated With Non Alcoholic Fatty Liver Disease In Euthyroid Subjects The Lifelines Cohort Study

This large study examined the relationship between thyroid hormones and non-alcoholic fatty liver disease (NAFLD) in over 20,000 people with normal thyroid function. NAFLD is a condition where excess fat builds up in the liver, often related to obesity and metabolic problems, and it affects roughly 25% of adults worldwide.

The researchers found that people with higher levels of free T3 (triiodothyronine) - one of the main thyroid hormones - were more likely to have fatty liver disease, even when their overall thyroid function was completely normal. Specifically, they discovered that for every standard increase in T3 levels, there was a 34% higher chance of having NAFLD. Interestingly, higher levels of T4 (thyroxine), the other main thyroid hormone, were actually associated with lower risk of fatty liver disease.

This finding is significant because it suggests that even subtle variations in thyroid hormones within the "normal" range can impact liver health and fat metabolism. The liver plays a crucial role in processing fats and cholesterol, and thyroid hormones directly influence how the liver handles these substances. This research helps explain why some people may be more prone to developing fatty liver disease despite having apparently normal thyroid function.

For clinical practice, this research suggests that monitoring thyroid hormone levels - particularly the balance between T3 and T4 - could be valuable in assessing metabolic health risks. It may also inform more personalized approaches to preventing and treating fatty liver disease, especially in patients with metabolic syndrome or other risk factors.